Core Viewpoint - JPMorgan has increased its stake in Heng Rui Medicine (01276) by acquiring 1,127,828 shares at a price of HKD 74.6126 per share, totaling approximately HKD 84.15 million, raising its ownership to about 19.19 million shares, which represents a 7.43% stake in the company [2][4]. Summary by Category - Investment Activity - JPMorgan's recent purchase of 1,127,828 shares indicates a strategic move to bolster its investment in Heng Rui Medicine [2][4]. - The total investment amount for this transaction is approximately HKD 84.15 million [2][4]. - Ownership Structure - Following the acquisition, JPMorgan's total shareholding in Heng Rui Medicine has increased to approximately 19.19 million shares [2][4]. - The new ownership percentage stands at 7.43% of the total shares [2][4].